Next Article in Journal
Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges
Next Article in Special Issue
From Pathways to Practice: Impact of Implementing Mobilization Recommendations in Head and Neck Cancer Surgery with Free Flap Reconstruction
Previous Article in Journal
Coordinating Effect of VEGFC and Oleic Acid Participates to Tumor Lymphangiogenesis
Previous Article in Special Issue
Sinonasal Squamous Cell Carcinoma, a Narrative Reappraisal of the Current Evidence
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Impact of Early Mobilization on Recovery after Major Head and Neck Surgery with Free Flap Reconstruction

1
Ohlson Research Initiative, Arnie Charbonneau Research Institute, University of Calgary Cumming School of Medicine, 3280 Hospital Dr. NW, Calgary, AB T2N 4Z6, Canada
2
O’Brien Institute of Public Health, Cumming School of Medicine, University of Calgary, 3280 Hospital Dr. NW, Calgary, AB T2N 4Z6, Canada
3
Section of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Calgary Cumming School of Medicine, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, Canada
4
Foothills Medical Centre, Alberta Health Services, 1403 29 St NW, Calgary, AB T2N 2T9, Canada
5
Section of Plastic and Reconstructive Surgery, Department of Surgery, University of Calgary Cumming School of Medicine, 3330 Hospital Dr. NW, Calgary, AB T2N 4N1, Canada
6
Departments of Community Health Sciences, Surgery & Oncology University of Calgary Cumming School of Medicine, 3D10, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, Canada
*
Authors to whom correspondence should be addressed.
Cancers 2021, 13(12), 2852; https://doi.org/10.3390/cancers13122852
Submission received: 23 April 2021 / Revised: 29 May 2021 / Accepted: 2 June 2021 / Published: 8 June 2021
(This article belongs to the Special Issue Surgical Treatment of Head and Neck Squamous Cell Carcinomas (HNSCC))

Abstract

:

Simple Summary

For patients diagnosed with head and neck cancer (HNC), surgery to remove the tumour is a standard treatment. The surgery is complex-in most cases, the mouth and throat need to be rebuilt using tissue from another area of the body to restore appearance and function. Recovery from HNC surgery is challenging, and complications occur frequently. It is recommended that patients get out of bed and move (are “mobilized”) as early as possible after surgery (within 24 h) to improve recovery. However, evidence for this recommendation mainly comes from other types of cancer. Therefore, this study investigated whether early mobilization impacts recovery in patients undergoing HNC surgery. We found that delaying mobilization (after 24 h) was linked with more complications and a longer stay in the hospital. Helping patients mobilize within 24 h after HNC surgery should be a priority for healthcare teams.

Abstract

Surgery with free flap reconstruction is a standard treatment for head and neck cancer (HNC). Because of the complexity of HNC surgery, recovery can be challenging, and complications are common. One of the foundations of enhanced recovery after surgery (ERAS) is early postoperative mobilization. The ERAS guidelines for HNC surgery with free flap reconstruction recommend mobilization within 24 h. This is based mainly on evidence from other surgical disciplines, and the extent to which mobilization within 24 h improves recovery after HNC surgery has not been explored. This retrospective analysis included 445 patients from the Calgary Head and Neck Enhanced Recovery Program. Mobilization after 24 h was associated with more complications of any type (OR = 1.73, 95% CI [confidence interval] = 1.16–2.57) and more major complications (OR = 1.76; 95% CI = 1.00–3.16). When accounting for patient and clinical factors, mobilization after 48 h was a significant predictor of major complications (OR = 2.61; 95% CI = 1.10–6.21) and prolonged length of stay (>10 days; OR = 2.85, 95% CI = 1.41–5.76). This comprehensive analysis of the impact of early mobilization on postoperative complications and length of stay in a large HNC cohort provides novel evidence supporting adherence to the ERAS early mobilization recommendations. Early mobilization should be a priority for patients undergoing HNC surgery with free flap reconstruction.

1. Introduction

Head and neck cancer (HNC) ranks amongst the top ten most common types of cancer worldwide [1]. Surgery with free flap reconstruction is a standard treatment for HNC. Resection of head and neck tumours can involve removing critical structures required for speech and swallowing, leaving patients with significant functional impairments. Patients face numerous challenges across the surgical timeline and an extended recovery in the hospital (often 10 days or longer) [2]. At least two-thirds of patients have a postoperative medical or surgical complication in the days after surgery [3]. HNC-specific care pathways optimize care before, during and after these complicated surgical procedures [2,4]. Care pathways specify perioperative interventions and timelines to achieve optimal clinical outcomes and reduce the costs of care. Enhanced recovery after surgery (ERAS) guidelines were initially developed for colorectal cancer [5] but have subsequently been developed for many other surgical disciplines [6] and have become widely adopted. An ERAS guideline for head and neck surgery with free flap reconstruction was published in 2017 [4].
One of the foundations of ERAS is early postoperative mobilization [6]. Mobilization includes sitting, standing, and walking as early as possible after surgery. Although traditionally, HNC surgeons may have recommended bed rest or activity restrictions due to concerns about vascular flap failure, these concerns remain unsubstantiated [7,8]. It is now widely recognized that early mobilization is important to optimize postoperative clinical outcomes [9]. Few studies, however, have examined the impact of early mobilization after HNC surgery with free flap reconstruction. Over the past decade, the field of enhanced recovery has advanced greatly, yet there has been only one retrospective cohort and one randomized trial investigating postoperative mobilization and clinical outcomes after HNC surgery [7,8]. Yeung et al. (2013) [7] found that patients mobilized after postoperative day (POD) four were four times more likely to develop pneumonia. Similarly, Yang et al. (2020) [8] found that an early mobilization intervention (off-bed activity on POD three) was associated with reduced time to removal of nasogastric tubes, urethral catheters and tracheostomies; and was also associated with longer sleep duration and improved patient comfort. Given the evidence in HNC and other surgical disciplines, the ERAS guideline for HNC surgery now recommends mobilization within 24 h (moderate evidence, strong recommendation) [4]. The extent to which mobilization within 24 h improves recovery has not been explored, especially in a large cohort of patients with HNC undergoing major head and neck resection and free flap reconstruction.
The Calgary Head and Neck Enhanced Recovery Program (CHERP), which has been in place since 2012, was adapted to include additional head and neck ERAS elements in late 2017, and the combined CHERP/ERAS program continues to the present time. This retrospective cohort study explored the association between early mobilization (using the CHERP/ERAS pathway) and clinical and process of care outcomes among patients with HNC undergoing surgery with free flap reconstruction. The specific objectives of this study were: (1) To describe time to postoperative mobilization and the proportion of patients mobilized within the pathway recommended timeframe; (2) to understand the association between early mobilization and postoperative complications and length of stay (LOS), including how patient and clinical variables modify the association; (3) to understand the association between patient and clinical variables and delayed postoperative mobilization.

2. Materials and Methods

This was a retrospective cohort study. Data were collected prospectively as standard practice in the CHERP, which is part of a comprehensive continuous quality improvement program [2,10].

2.1. Setting

Alberta is a province in Western Canada with a population of 4.4 million (October 2020) [11]. Healthcare in Alberta is delivered through a single health service provider (Alberta Health Services) within a universal, publicly funded healthcare system. All surgeries were performed at Foothills Medical Centre in Calgary, which is the tertiary referral centre for major HNC surgery with free flap reconstruction in Southern Alberta. The study was conducted from 4 June 2012, until 31 September 2020.

2.2. Participants

All patients over 18 years old who underwent resection with free flap reconstruction for head and neck malignancies, benign tumours or complications of other treatments (e.g., osteoradionecrosis) were included in this study. Patients were excluded if data for early mobilization (pathway data) were missing, if they were aged < 18 years old and if they had surgery without free flap reconstruction.

2.3. Enhanced Recovery Pathway

The CHERP includes an established measurement, audit and feedback system and care pathway elements are delivered using computerized order sets [2]. In addition to postoperative mobilization, the pathway includes care elements such as preadmission education, perioperative nutritional care, prophylaxis against thromboembolism, postoperative nausea/vomiting prophylaxis, urinary catheterization, tracheostomy management, postoperative flap monitoring, wound management, and pulmonary physical therapy. Two additional ERAS elements were added in December 2017: a perioperative multimodal analgesia protocol and an intraoperative fluid management protocol. The protocol for early mobilization was the same in both the CHERP and ERAS pathways. The majority of patients undergoing major resection with free flap reconstruction are managed overnight in the intensive care unit (ICU) and then transferred to a ward staffed by clinicians specialized in managing head and neck surgical patients. A minority are transferred directly to the ward.

2.4. Data Sources

The pathway is fully integrated into the inpatient electronic medical record, which is the source of the clinical data used in this study. Clinical data, as defined by the minimum data set, are prospectively collected by a trained research assistant who is embedded in the hospital inpatient unit [10]. Clinical data are obtained through a combination of paper chart review and data abstraction from the EMR. Information on complications is recorded in the chart by the most responsible physician (attending or resident). Charts are reviewed by a trained professional for sentinel events, and physician and allied health professional notes are reviewed to obtain information on important pathway milestones, including mobilization time. Diagnostic imaging reports are also reviewed to supplement paper charts and EMR data.

2.5. Bias

Data were collected prospectively by a trained professional and not by the research team, minimizing selection bias and improving reliability. We inspected the demographic characteristics of patients with and without mobilization data to check for evidence of selection bias.

2.6. Outcomes

To understand the association between early mobilization and postoperative complications and LOS, the primary outcomes were any complications, severe complications and a prolonged LOS. Two dichotomized variables were created to examine postoperative complications: (1) Occurrence of any complication (yes, no) was defined as any deviation from the normal postoperative course and was classified as grade I–V using the Clavien-Dindo classification [12]. (2) Major complications (yes, no) were defined as grade IIIb–V using the Clavien-Dindo classification, which includes complications requiring surgical, endoscopic or radiological intervention under general anesthesia, life-threatening complications and death [12]. In separate analyses, we also used dichotomous complication variables (yes, no) to examine specific complication types, including: pneumonia, pulmonary embolism, deep vein thrombosis, delirium tremens, myocardial infarction, bleed or hematoma, free flap compromise and failure. LOS was dichotomized as POD 0-10 and POD >10 (the latter representing a prolonged LOS), and this cut-point was based on both the median LOS and the pathway recommended LOS. In addition, LOS is also reported as a continuous variable.

2.7. Time to Postoperative Mobilization (Exposure)

The date of first meaningful mobilization was recorded as the date where there was evidence that the patient was mobilized out of bed, up in a chair, standing and/or walking. Time to mobilization was calculated as the number of calendar days from the date of surgery (POD 0) to the date of first meaningful mobilization. Postoperative early mobilization was also categorized as POD 0–1 (a surrogate for mobilization within 24 h postoperative, in line with current pathway recommendations [4]) vs. POD > 1 (mobilization after 24 h postoperative. Postoperative mobilization was also categorized as POD 0–2 (a surrogate for within 48 h) and POD > 2 (mobilization after 48 h postoperative). To examine the association between early mobilization and postoperative complications and LOS, delayed postoperative mobilization (after 24 h) was considered an exposure. To understand the association between patient and clinical variables and delayed postoperative mobilization, delayed postoperative mobilization was the outcome.

2.8. Variables

Potential predictor variables of complications, a prolonged LOS and delayed mobilization, were identified through the existing evidence and expert consultation with the research team. Preoperative variables included age (centred at the mean), sex (male or female), smoking status (never, former or current smoker), alcohol habits (never, former, light/moderate, heavy), body mass index (BMI; standard categories for underweight, healthy range, overweight and obese based on kg/m [2]), primary cancer site (oral cavity, pharynx and larynx, skin, other), cancer stage (0–II and III–IV), and the number of comorbidities (none, one or at least two). Intraoperative and postoperative variables included presence of tracheostomy, number of free flaps, flap donor type (radial forearm, fibula, anterolateral thigh, other), resection extent (soft tissue, bone or soft tissue and bone) and arrival to the hospital unit from the ICU as POD 0–1 vs. POD > 1 (a surrogate for the duration of the ICU admission).

2.9. Statistical Methods

All data were analyzed using Stata 16.1 (Stata Corp, College Station, TX, USA) [13] and alpha was set at 0.05 for all statistical tests. To describe patient characteristics, time to postoperative mobilization and the proportion of patients mobilized within the pathway recommended timeframe; data were summarized as frequencies (percentages) for categorical variables, range, median (interquartile range) or mean (standard deviation, SD) for continuous variables. To compare demographic and clinical characteristics between patients who were mobilized early and those who were not, two-tailed Fisher’s exact tests for r × c contingency tables (alcohol status, smoking status, comorbidities, primary site, clinical-stage, number of free flaps) and independent t-test (age on the date of surgery) were used [14]. To test the univariable associations between time to mobilization and postoperative complications and LOS, a two-tailed Fisher’s exact tests (any complication, major complications including pneumonia, pulmonary embolism, deep vein thrombosis, delirium tremens, myocardial infarction, bleed or hematoma, free flap compromise, flap failure, LOS dichotomized at POD 10) and a Mann U Whitney test (LOS as a continuous variable) were used.
To explore the associations between potential predictors and postoperative complications and a prolonged LOS, multivariable logistic regression was used. To improve the predictive performance of the regression models, we used a method of variable selection called elastic net regularization [15]. This method was chosen because of the high number of potential predictor variables and its ability to guide the selection of the most relevant variables while simultaneously minimizing model overfitting. This method combines the Least Absolute Shrinkage and Selection Operator (LASSO) and ridge methods of variable selection. LASSO uses a penalty function to shrink regression coefficients and selects for only the most important regressors. The elastic net extends the LASSO by adding a quadratic term to the penalty function and was designed to produce better predictions and model performance when covariates are highly correlated. We also examined the assumption of collinearity of (non-binary) predictor variables using the “collin” package in Stata and a variance inflation factor (a measure of the amount of multicollinearity in a set of multiple regression variables) cut-point of <5. Variables selected by elastic net regularization were subsequently entered into the logistical regression models. This process was repeated to examine the association between patient and clinical variables and delayed postoperative mobilization. The Akaike information criterion (AIC) is reported for each model [16]. The reference levels for the categorical variables in all models were: BMI = healthy range; sex = male; smoking status = never; alcohol status = never; comorbidity = none; primary site = Oral Cavity; Cancer stage = I–II; flap count = one; resection extent = soft tissue only; flap donor site = radial forearm; mobilization = POD 0–1 (within 24 h) and POD 0–2 (within 48 h).

3. Results

Mobilization (pathway) data were missing in 11% (n = 55) of cases. Less than 5% of data for complications and LOS were missing. We did not identify any imbalance of prognostic factors between eligible patients with and without pathway data (Table S1), suggesting no selective exclusion of patients. Missing data were missing at random either due to failure to flag a case for data collection or a failure to record mobilization milestones in the chart.
Major resection with free flap volumes varied between a minimum of 43 and a maximum of 75 cases per year during this study. There were 500 eligible patients between 4 June 2012, and 31 September 2020. Of this sample, n = 445 patients had pathway data and were included in this analysis. Characteristics of the study cohort are presented in Table 1; briefly, patients were aged 61.2 ± 12.2 (mean ± SD) years, predominantly male (68%) with stage III–IV (65%) squamous cell carcinoma (80%). Postoperative mobilization time ranged from 0–32 days with a median of 2 days (IQR [interquartile range] = 1–2). We found that 44% of patients were mobilized within 24 h, 77% of patients were mobilized within 48 h, and 91% of patients were mobilized within 72 h after surgery. A minority of patients (5%) had not been mobilized by POD 4.

3.1. Postoperative Complications

A total of 242 (45%) of patients had a complication, and 70 (16%) of these were major, including loss of flap in five cases (1%). In univariable analyses, mobilization after 24 h was associated with more complications (OR = 1.73 [95% CI = 1.16–2.57]; p = 0.005) and more major complications (OR = 1.76 [95% CI = 1.00–3.16]; p = 0.049; Table 2). This association persisted among those mobilized after 48 h (OR for any complication = 2.08 [95% CI = 1.28–3.43]; p = 0.002 and OR for major complications = 2.28 [95% CI = 1.26–4.05]; p = 0.005). Furthermore, mobilization after 48 h was associated with more cases of pneumonia (OR = 4.07 [95% CI = 1.92–8.59]; p < 0.001); 5% of patients mobilized within 48 h developed pneumonia compared to 18% of patients mobilized after 48 h (Table 2 and Table S2).
In multivariable analyses, we found that patients who were older, had one or more comorbidities and had more advanced stages of cancer were more likely to have any complication (AIC = 483; Table S3). Patients who were current smokers had two or more comorbidities, whose flap type was “other”, and who were mobilized after 48 h were more likely to have a major complication (AIC = 312; Figure 1).

3.2. Hospital Length of Stay

LOS ranged from 4–114 days with an overall median of 11 days (IQR = 8–15). In univariable analyses, patients with delayed mobilization (after 24 h) were more likely to be discharged after 10 days postoperatively (OR = 1.80 [95% CI = 1.21–2.68]; p < 0.003). Patients who were mobilized after 48 h stayed in the hospital four days longer (median difference) than those who were mobilized within 48 h (p < 0.001; Table 2). In multivariable analyses, mobilization after POD 2 was a predictor of a prolonged LOS (OR = 2.85 [95% CI = 1.41–5.76]; p = 0.004). Other significant predictors of a prolonged LOS included older age, a tracheostomy, any complication and primary cancer site (pharynx/larynx; AIC = 384; Table S4).

3.3. Delayed Mobilization

Multivariable predictors of delayed mobilization (mobilization after 24 h) were the presence of a tracheostomy (OR = 2.81 [95% CI = 1.70–6.37]; p < 0.001) and a longer ICU admission (OR = 3.29 [95% CI = 1.70–6.37]; p < 0.001; AIC = 576; Table S5).

4. Discussion

In this study, we found that patients who were mobilized early had fewer complications overall, fewer major complications, and a shorter LOS. When accounting for relevant patient and clinical variables, mobilization after 48 h predicted major complications and a prolonged LOS (hospital discharge after POD 10). The main predictors of delayed mobilization were an extended ICU admission and having a tracheostomy. This comprehensive analysis demonstrates the impact of early mobilization on postoperative complications and LOS in this important surgical group. Our study provides new HNC-specific evidence to support the ERAS recommendation that patients should be mobilized within 24 h after surgery where possible.
Postoperative complications are common for patients undergoing major HNC surgery (45% in the present study) and have been associated with increased LOS, morbidity and decreased overall survival [17]. Early postoperative mobilization is an established component of ERAS based on counteracting catabolic changes with bed rest, prophylaxis of pulmonary embolism and deep vein thrombosis, and supporting a return to normal function. ERAS guidelines for HNC surgery give early mobilization a strong recommendation [4] despite relatively little evidence in this patient group. To our knowledge, an association between mobilization with 24 h, complications and LOS has not previously been reported in this patient population. In a cohort of 62 patients, our group previously reported that mobilization after POD 4 was associated with an increased incidence of pneumonia [7]. Our current study-conducted in a much larger cohort and using methods that minimize statistical modelling error-enables a more comprehensive understanding of the association between mobilization and important clinical and process outcomes. We replicate our previous finding for pneumonia and show that the incidence of pneumonia was three times higher in patients who were mobilized after POD 2 in the current cohort. Therefore, these findings suggest that ERAS recommendations pertaining to early mobilization are worthy of focused attention by clinical teams working with this patient population. Other surgical disciplines with ERAS guidelines also have explored whether early mobilization predicts objective markers of recovery, considering ERAS involves numerous care elements (17 in HNC [4]). In particular, early mobilization is a predictor of morbidity, complication severity and LOS after colorectal cancer surgery [18,19,20].
Using data from a large cohort of 445 patients collected over the past eight years, we found that the overall proportion of patients mobilized within 24 h was 44%, and 77% were moving by POD 2. Our study extends the work of others on compliance with ERAS early mobilization targets after HNC surgery [21,22,23,24,25]. In 2016, motivated by data showing suboptimal mobilization performance, our pathway target was adjusted with beneficial results. These efforts to improve mobilization compliance since 2016 are described in our companion paper. To improve mobilization, barriers to mobilization compliance were explored. We found that primary predictors of delayed mobilization are a longer ICU admission and the presence of a tracheostomy. To facilitate early mobilization, other institutions with ERAS protocols avoid ICU admission if medically suitable, through a combination of a rapid wake-up protocol developed by the anesthesia team and tracheostomy care and free flap monitoring taking place on the unit by a trained nursing team [21]. Where feasible, this requires further consideration in future advancements of HNC-specific ERAS pathways. However, we believe that future research should also explore the benefits of physical activity in the waiting period before HNC surgery [26] and build on promising early evidence that postoperative exercise (in addition to standard physical therapy) reduces LOS [27].
A limitation of the present analysis and the wider body of research on early mobilization after surgery lies in the accuracy of the measurement of mobilization. In the CHERP and many other enhanced recovery pathways for HNC surgery, mobilization has only been evaluated as the interval of days between surgery and mobilization, with variable definitions of what counts as mobilization [28]. The need for consistent charting places an undue burden on the healthcare team [29], and although this metric indicates how quickly a person begins to mobilize after surgery, it provides no information on how much. Avoiding bed rest, preventing functional decline and progressing towards preoperative activity levels helps patients meet discharge criteria earlier and sets the stage for a seamless transition to recovery at home. ERAS pathways for HNC surgery have begun to measure step counts objectively using pedometers [25], and commercially-available wearable technology offers a more sophisticated solution that could be integrated within the EMR. An objective measure of mobilization would improve understanding of the dose-response relationship: the quantity of mobilization (e.g., number of daily step counts) that is safe and associated with improved patient outcomes [30]. Wearable technology can provide continuous feedback on activity across the hospital stay, which can be used by patients, the clinical team, and in prospective trials involving mobilization interventions [29].
Our study has several strengths, including a large cohort of consecutively treated patients (which permits exploration of more covariates and enables better statistical modelling), treated with a consistent care team and computerized order entry (which facilitates more reliable delivery of clinical care). However, there are some limitations that should be considered when interpreting our findings. Data were collected within one centre in Alberta, Canada, and we acknowledge that enhanced recovery pathways must be tailored to the local setting and resources. Although we have extended the evidence of the importance of mobilization within 24 h after HNC surgery, similar analyses from other institutions will support the generalizability of our findings. The retrospective nature of this study limited our ability to assess the timing of all complications in relation to early mobilization, limiting our understanding about the causal relationship between mobilization and complications. Some of the complications that are most likely to occur early in the postoperative period are bleeding, hematoma, and flap compromise [31,32]. However, in the majority of cases, patients were mobilized before these major complications are likely to have occurred. Therefore, we do not believe that the lack of high-resolution data on the timing of complications confuses the associations described in this study. Similarly, data on postoperative nausea and vomiting was not extractable for data analysis, though adequate control of this symptom is needed for effective mobilization [33]. Finally, we were unable to include the Charlson comorbidity index. Establishing causality requires other research designs, and the results of this study should be interpreted with due caution. However, our data add to findings from other surgical specialties and suggest that interventions that target mobilization during the perioperative period for patients undergoing HNC surgery are an avenue for future research to improve clinical outcomes.

5. Conclusions

Mobilization within 24 h was associated with fewer complications, fewer major complications, and a significantly shorter LOS in a large sample of patients undergoing head and neck surgery with free flap reconstruction. Mobilization after 48 h was a predictor of major complications and a longer LOS. Therefore, early mobilization should be a priority when caring for patients undergoing major HNC resection with free flap reconstruction and should be included in enhanced recovery pathways as recommended by ERAS guidelines. Future prospective research integrating wearable technology may provide further insight into the relationship between increased mobilization and improved patient outcomes.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/cancers13122852/s1, Table S1: Patient characteristics and missing data, Table S2: Patient characteristics and mobilization within or after 48 h, Table S3: Predictors of any postoperative complication and major postoperative complications using elastic net regularization followed by multivariable logistic regression, Table S4: Predictors of hospital length of stay using elastic net regularization followed by multivariable logistic regression, Table S5: Predictors of delayed mobilization (after 24 h) using elastic net regularization followed by multivariable logistic regression.

Author Contributions

Conceptualization: R.T., K.M.S. & J.C.D.; Methodology: R.T., K.M.S., N.L. & J.C.D.; Validation: R.T., K.M.S., S.N., N.L. & J.C.D.; Writing—original draft preparation: R.T. & K.M.S.; Writing—review and editing: R.T., T.W.M., S.N., C.S., S.P.C., J.M., D.M., R.D.H., N.L., J.C.D., K.M.S.; Supervision, K.M.S. & J.C.D.; Project administration: S.N. & J.C.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding but was supported by the Ohlson Research Initiative.

Institutional Review Board Statement

All data analyzed in this study were part of routine data collection in the Calgary Head & Neck Enhanced Recovery Program. A Project Ethics Community Consensus Initiative (ARECCI) framework was used to assess for and mitigate ethical risks, including the four-step ARECCI Ethics Screening Tool and the ARECCI Ethics Guidelines [34]. The project purpose was deemed quality improvement and program evaluation, with minimal risk to participants, and did not require review from a Research Ethics Board.

Informed Consent Statement

Patient consent was waived due to the project being deemed a quality improvement and program evaluation initiative and part of usual clinical practice.

Data Availability Statement

The data for this study are under the custodianship of Alberta Health Services (AHS) and are therefore unavailable for sharing. Data can be made available after an appropriate data sharing, and access agreement is formally completed. Please contact Dort for more information ([email protected]).

Acknowledgments

The authors gratefully acknowledge the support of the Ohlson Research Initiative for sustaining the data collection, analytics and reporting infrastructure that is a foundational and ongoing part of this work. We also acknowledge the support of Alberta Health Services in implementing and maintaining the computerized order sets that are critically important to the inpatient care delivery system. Finally, we acknowledge the AHS staff who diligently use the Calgary Head and Neck Enhanced Recovery Program protocol in their day-to-day work.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Dort, J.C.; Sauro, K.M.; Chandarana, S.; Schrag, C.; Matthews, J.; Nakoneshny, S.; Manoloto, V.; Miller, T.; McKenzie, C.D.; Hart, R.D.; et al. The impact of a quality management program for patients undergoing head and neck resection with free-flap reconstruction: Longitudinal study examining sustainability. J. Otolaryngol. Head Neck Surg. 2020, 49, 1–9. [Google Scholar] [CrossRef]
  3. Lahtinen, S.; Koivunen, P.; Ala-Kokko, T.; Kaarela, O.; Ohtonen, P.; Laurila, P.; Liisanantti, J. Complications and outcome after free flap surgery for cancer of the head and neck. Br. J. Oral Maxillofac. Surg. 2018, 56, 684–691. [Google Scholar] [CrossRef] [Green Version]
  4. Dort, J.C.; Farwell, D.G.; Findlay, M.; Huber, G.F.; Kerr, P.; Shea-Budgell, M.; Simon, C.; Uppington, J.; Zygun, D.; Ljungqvist, O.; et al. Optimal perioperative care in major head and neck cancer surgery with free flap reconstruction: A consensus review and recommendations from the Enhanced Recovery After Surgery Society. JAMA Otolaryngol. Head Neck Surg. 2017, 143, 292–303. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Fearon, K.C.H.; Ljungqvist, O.; Von Meyenfeldt, M.; Revhaug, A.; Dejong, C.; Lassen, K.; Nygren, J.; Hausel, J.; Soop, M.; Andersen, J.; et al. Enhanced recovery after surgery: A consensus review of clinical care for patients undergoing colonic resection. Clin. Nutr. 2005, 24, 466–477. [Google Scholar] [CrossRef]
  6. Ljungqvist, O.; Scott, M.; Fearon, K.C. Enhanced recovery after surgery: A review. JAMA Surg. 2017, 152, 292–298. [Google Scholar] [CrossRef]
  7. Yeung, J.K.; Harrop, R.; McCreary, O.; Leung, L.T.; Hirani, N.; McKenzie, D.; De Haas, V.; Matthews, T.W.; Nakoneshny, S.; Dort, J.C.; et al. Delayed mobilization after microsurgical reconstruction: An independent risk factor for pneumonia. Laryngoscope 2013, 123, 2996–3000. [Google Scholar] [CrossRef]
  8. Yang, Y.; Wu, H.; Wei, L.; Li, P.; Cai, Z.; Shan, X. Improvement of the patient early mobilization protocol after oral and maxillofacial free flap reconstruction surgery. J. Cranio Maxillofac. Surg. 2020, 48, 43–48. [Google Scholar] [CrossRef]
  9. Gordon, S.A.; Reiter, E.R. Effectiveness of critical care pathways for head and neck cancer surgery: A systematic review. Head Neck 2016, 38, 1421–1427. [Google Scholar] [CrossRef]
  10. Dort, J.C.; Sauro, K.M.; Schrag, C.; Chandarana, S.; Matthews, J.; Nakoneshny, S.; Manoloto, V.; Miller, T.; McKenzie, C.D.; Hart, R.D.; et al. Designing and integrating a quality management program for patients undergoing head and neck resection with free-flap reconstruction. J. Otolaryngol. Head Neck Surg. 2020, 49, 1–9. [Google Scholar] [CrossRef] [PubMed]
  11. The Government of Alberta. Population Statistics. Available online: https://www.alberta.ca/population-statistics.aspx (accessed on 17 February 2021).
  12. Clavien, P.A.; Barkun, J.; de Oliveira, M.L.; Vauthey, J.N.; Dindo, D.; Schulick, R.D.; de Santibañes, E.; Pekolj, J.; Slankamenac, K.; Bassi, C.; et al. The Clavien-Dindo classification of surgical complications: Five-year experience. Ann. Surg. 2009, 250, 187–196. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. StataCorp. Stata Statistical Software: Release 16; StataCorp LLC.: College Station, TX, USA, 2019. [Google Scholar]
  14. Mehta, C.R.; Patel, N.R. A network algorithm for performing Fisher’s exact test in R × C contingency tables. J. Am. Stat. Assoc. 1983, 78, 427–434. [Google Scholar] [CrossRef]
  15. Zou, H.; Hastie, T. Regularization and Variable Selection via the Elastic Net. J. R. Stat. Soc. Ser. B Stat. Methodol. 2005, 67, 301–320. [Google Scholar] [CrossRef] [Green Version]
  16. Akaike, H. A new look at the statistical model identification. IEEE Trans. Autom. Control 1974, 19, 716–723. [Google Scholar] [CrossRef]
  17. Ch’ng, S.; Choi, V.; Elliott, M.; Clark, J.R. Relationship between postoperative complications and survival after free flap reconstruction for oral cavity squamous cell carcinoma. Head Neck 2014, 36, 55–59. [Google Scholar] [CrossRef]
  18. Vlug, M.S.; Bartels, S.A.L.; Wind, J.; Ubbink, D.T.; Hollmann, M.W.; Bemelman, W.A. Which fast track elements predict early recovery after colon cancer surgery? Colorectal Dis. 2012, 14, 1001–1008. [Google Scholar] [CrossRef]
  19. Bakker, N.; Cakir, H.; Doodeman, H.J.; Houdijk, A.P.J. Eight years of experience with Enhanced Recovery After Surgery in patients with colon cancer: Impact of measures to improve adherence. Surgery 2015, 157, 1130–1136. [Google Scholar] [CrossRef] [PubMed]
  20. Pecorelli, N.; Hershorn, O.; Baldini, G.; Fiore, J.F.; Stein, B.L.; Liberman, A.S.; Charlebois, P.; Carli, F.; Feldman, L.S. Impact of adherence to care pathway interventions on recovery following bowel resection within an established enhanced recovery program. Surg. Endosc. 2017, 31, 1760–1771. [Google Scholar] [CrossRef] [PubMed]
  21. Low, G.M.I.; Kiong, K.L.; Amaku, R.; Kruse, B.; Zheng, G.; Weber, R.S.; Lewis, C.M. Feasibility of an Enhanced Recovery After Surgery (ERAS) pathway for major head and neck oncologic surgery. Am. J. Otolaryngol. 2020, 41, 102679. [Google Scholar] [CrossRef]
  22. Coyle, M.J.; Main, B.; Hughes, C.; Craven, R.; Alexander, R.; Porter, G.; Thomas, S. Enhanced recovery after surgery (ERAS) for head and neck oncology patients. Clin. Otolaryngol. 2016, 41, 118–126. [Google Scholar] [CrossRef] [PubMed]
  23. Gemma, M.; Toma, S.; Lira Luce, F.; Beretta, L.; Braga, M.; Bussi, M. Enhanced recovery program (ERP) in major laryngeal surgery: Building a protocol and testing its feasibility. Acta Otorhinolaryngol. Ital. 2017, 37, 475–478. [Google Scholar] [CrossRef]
  24. Jandali, D.B.; Vaughan, D.; Eggerstedt, M.; Ganti, A.; Scheltens, H.; Ramirez, E.A.; Revenaugh, P.C.; Al-Khudari, S.; Smith, R.M.; Stenson, K.M. Enhanced recovery after surgery in head and neck surgery: Reduced opioid use and length of stay. Laryngoscope 2020, 130, 1227–1232. [Google Scholar] [CrossRef] [PubMed]
  25. Imai, T.; Kurosawa, K.; Asada, Y.; Momma, Y.; Takahashi, M.; Satake, N.; Azuma, M.; Suzuki, A.; Sasaki, M.; Morita, S.; et al. Enhanced recovery after surgery program involving preoperative dexamethasone administration for head and neck surgery with free tissue transfer reconstruction: Single-center prospective observational study. Surg. Oncol. 2020, 34, 197–205. [Google Scholar] [CrossRef]
  26. Twomey, R.; Culos-Reed, S.N.; Dort, J.C. Exercise prehabilitation-supporting recovery from major head and neck cancer surgery. JAMA Otolaryngol. Head Neck Surg. 2020, 8, 689–690. [Google Scholar] [CrossRef] [PubMed]
  27. Steegmann, J.; Bartella, A.K.; Kloss-Brandstätter, A.; Kamal, M.; Hölzle, F.; Lethaus, B. A randomized clinical trial on the efficacy of a patient-adapted autonomous exercise regime for patients with head and neck cancer. J. Cranio Maxillofac. Surg. 2020, 48, 187–192. [Google Scholar] [CrossRef]
  28. Neville, A.; Lee, L.; Antonescu, I.; Mayo, N.E.; Vassiliou, M.C.; Fried, G.M.; Feldman, L.S. Systematic review of outcomes used to evaluate enhanced recovery after surgery. Br. J. Surg. 2014, 101, 159–170. [Google Scholar] [CrossRef]
  29. Twomey, R.; Culos-Reed, S.N.; Daun, J.T.; Ferber, R.; Dort, J.C. Wearable activity trackers and mobilization after major head and neck cancer surgery: You can’t improve what you don’t measure. Int. J. Surg. 2020, 84, 120–124. [Google Scholar] [CrossRef]
  30. Daskivich, T.J.; Houman, J.; Lopez, M.; Luu, M.; Fleshner, P.; Zaghiyan, K.; Cunneen, S.; Burch, M.; Walsh, C.; Paiement, G.; et al. Association of wearable activity monitors with assessment of daily ambulation and length of stay among patients undergoing major surgery. JAMA Netw. Open 2019, 2, e187673. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Pohlenz, P.; Klatt, J.; Schön, G.; Blessmann, M.; Li, L.; Schmelzle, R. Microvascular free flaps in head and neck surgery: Complications and outcome of 1000 flaps. Int. J. Oral Maxillofac. Surg. 2012, 41, 739–743. [Google Scholar] [CrossRef]
  32. Chen, Y.-F.; Wang, T.-H.; Chiu, Y.-H.; Chang, D.-H. Postoperative Hematoma in Microvascular Reconstruction of the Head and Neck. Ann. Plast. Surg. 2018, 80 (Suppl. S1), S15–S20. [Google Scholar] [CrossRef]
  33. Schwartz, J.; Gan, T.J. Management of postoperative nausea and vomiting in the context of an Enhanced Recovery after Surgery program. Best Pract. Res. Clin. Anaesthesiol. 2020, 34, 687–700. [Google Scholar] [CrossRef] [PubMed]
  34. Alberta Innovates ARECCI Ethics Guideline Tool. 2017. Available online: albertainnovates.ca/wp-content/uploads/2017/11/ARECCI-Ethics-Guideline-Tool.pdf (accessed on 1 January 2020).
Figure 1. A visual representation of the odds ratios and 95% confidence intervals for the multivariable logistic regression models of major postoperative complications (top panel) and a prolonged LOS (bottom panel). BMI = body mass index. POD = postoperative date. Flap count and resection extent were removed from this visualization due to wide confidence intervals (Table S3). The reference levels for the categorical variables were: Alcohol status = never; BMI = healthy range; sex = male; smoking status = never; alcohol status = never; comorbidity = none; primary site = Oral Cavity; Cancer stage = I–II; flap count = one; resection extent = soft tissue only; flap donor site = radial forearm; mobilization = POD 0–1 (within 24 h) and POD 0–2 (within 48 h).
Figure 1. A visual representation of the odds ratios and 95% confidence intervals for the multivariable logistic regression models of major postoperative complications (top panel) and a prolonged LOS (bottom panel). BMI = body mass index. POD = postoperative date. Flap count and resection extent were removed from this visualization due to wide confidence intervals (Table S3). The reference levels for the categorical variables were: Alcohol status = never; BMI = healthy range; sex = male; smoking status = never; alcohol status = never; comorbidity = none; primary site = Oral Cavity; Cancer stage = I–II; flap count = one; resection extent = soft tissue only; flap donor site = radial forearm; mobilization = POD 0–1 (within 24 h) and POD 0–2 (within 48 h).
Cancers 13 02852 g001
Table 1. Patient characteristics in for the cohort and for patients mobilized within (POD 0-1) or after (POD > 1) 24 h.
Table 1. Patient characteristics in for the cohort and for patients mobilized within (POD 0-1) or after (POD > 1) 24 h.
CharacteristicCohort n (%)
n = 445
POD 0–1 n (%)
n = 196
POD >1 n (%)
n = 249
p-Value
Sex
Male303 (68)132 (67)171 (69)0.838
Female142 (32)64 (33)78 (31)
Age (years)
Mean ± SD61.2 ± 12.261.4 ± 12.761.0 ± 12.20.371 *
Range21.2–89.0
Alcohol status 0.810
Never90 (20)36 (21)60 (23)
Light/Moderate162 (36)75 (43)102 (38)
Heavy93 (21)41 (24)73 (27)
Former48 (11)22 (13)32 (12)
Not reported52 (12)
Smoking status 0.664
Never smoked117 (26)52 (29)65 (28)
Former smoker151 (34)62 (35)89 (39)
Current smoker136 (31)63 (36)73 (32)
Not reported41 (9)
Comorbidities 0.660
None142 (32)64 (33)78 (31)
One136 (31)63 (32)73 (29)
Two or more167 (37)69 (35)98 (39)
Specific Comorbidity
Diabetes54 (12)25 (13)29 (12)0.771
COPD50 (11)22 (11)28 (11)1.000
Hypertension181 (41)70 (36)111 (45)0.065
Heart disease59 (13)22 (11)37 (15)0.324
Primary site 0.011
Oral cavity303 (68)121 (62)182 (73)
Pharynx & Larynx42 (8)18 (9)24 (10)
Skin39 (9)27 (14)12 (5)
Paranasal/Nasal27 (6)14 (7)13 (5)
Other34 (8)16 (8)18 (7)
Histology 0.098
Squamous cell356 (80)150 (77)206 (84)
Other cancer83 (18)38 (20)38 (16)
Benign6 (1)5 (3)1 (0)
Not reported7 (2)
Clinical stage 0.140
08 (2)1 (1)7 (3)
I44 (10)21 (12)23 (10)
II70 (16)38 (21)32 (14)
III66 (15)29 (16)37 (16)
IV223 (50)88 (50)135 (57)
Not reported34 (8)
Number of free flaps 0.828
One423 (95)187 (95)236 (95)
Two22 (5)9 (5)13 (5)
Flap type 0.359
Radial forearm235 (53)101 (52)134 (54)
Fibula95 (21)37 (19)58 (23)
Anterolateral thigh57 (13)30 (15)27 (11)
Other58 (13)28 (14)30 (12)
Resection Extent 0.267
Soft tissue329 (74)152 (78)177 (71)
Bone97 (22)38 (19)59 (24)
Soft tissue & bone19 (4)6 (3)13 (5)
Fisher’s exact tests were used for p-values, except for age (* independent t-test).
Table 2. Postoperative mobilization time, complications, and length of stay. The reference level for odds ratios is indicated with italics.
Table 2. Postoperative mobilization time, complications, and length of stay. The reference level for odds ratios is indicated with italics.
CharacteristicAll CasesPOD 0–1POD > 1OR95% CIp-ValuePOD 0–2POD > 2OR95% CIp-Value
n (%)445 (100)196 (44)249 (56) 342 (77)103 (23)
Any complication
Yes242 (45)92 (47)150 (60)1.731.16–2.570.005172 (50)70 (68)2.081.28–3.430.002
No202 (55)104 (53)98 (40) 169 (50)33 (32)
Major complication
Yes70 (16)23 (12)47 (19)1.761.00–3.160.04944 (13)26 (25)2.281.26–4.050.005
No374 (84)173 (88)201 (81) 297 (87)77 (75)
Pneumonia
Yes37 (8)11 (6)26 (10)1.900.91–4.510.08318 (5)19 (18)4.071.92–8.59<0.001
No408 (92)185 (94)223 (90) 324 (95)84 (82)
Pulmonary embolism
Yes2 (0)0 (0)2 (1)--0.5062 (1)0 (0)00–6.411.000
No443 (100)196 (100)247 (99) 340 (99)103 (100)
Delirium tremens
Yes19 (4)2 (1)17 (7)7.111.64–63.980.0035 (1)14 (14)10.603.46–38.36<0.001
No426 (96)194 (99)232 (93) 337 (99)89 (86)
Deep vein thrombosis
Yes3 (1)0 (0)3 (1)--0.2592 (1)1 (1)1.670.03–32.280.547
No442 (99)196 (100)246 (99) 340 (99)102 (99)
Bleeding
Yes18 (4)6 (3)12 (5)1.600.54–5.300.46912 (4)6 (6)1.700.51–5.040.389
No427 (96)190 (97)237 (95) 330 (96)97 (94)
Myocardial infarction
Yes7 (2)1 (1)6 (2)4.810.57–222.550.1413 (1)4 (4)4.570.75–31.550.053
No438 (98)195 (99)243 (98) 339 (99)99 (96)
Flap compromise
Yes38 (9)16 (8)22 (9)1.090.53–2.290.86527 (8)11 (11)1.390.60–3.040.421
No407 (91)180 (92)227 (91) 315 (92)92 (89)
Flap loss
Yes5 (1)2 (1)3 (1)1.180.13–14.291.0002 (1)3 (3)5.10.57–61.550.084
No440 (99)194 (99)246 (99) 340 (99)100 (97)
OR return
Yes68 (15)24 (12)44 (18)1.540.87–2.750.144046 (13)22 (21)1.750.94–3.160.061
No377 (85)172 (88)205 (82) 296 (87)81 (79)
Length of stay
POD 0-10204 (46)106 (54)98 (40)1.801.21–2.680.003178 (52)26 (25)3.231.93–5.51<0.001
After POD 10240 (55)90 (46)150 (60) 163 (48)77 (75)
Median (IQR) *11 (8–15)10 (8–14)11 (9–16)1 **−0.1–2.10.00310 (8–14)14 (10–19)4 **2.6–5.4<0.001
* Mann Whitney Test (all other tests are Fisher’s exact). ** Median difference. CI, confidence interval; OR, operating room; POD, postoperative day.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Twomey, R.; Matthews, T.W.; Nakoneshny, S.; Schrag, C.; Chandarana, S.P.; Matthews, J.; McKenzie, D.; Hart, R.D.; Li, N.; Sauro, K.M.; et al. Impact of Early Mobilization on Recovery after Major Head and Neck Surgery with Free Flap Reconstruction. Cancers 2021, 13, 2852. https://doi.org/10.3390/cancers13122852

AMA Style

Twomey R, Matthews TW, Nakoneshny S, Schrag C, Chandarana SP, Matthews J, McKenzie D, Hart RD, Li N, Sauro KM, et al. Impact of Early Mobilization on Recovery after Major Head and Neck Surgery with Free Flap Reconstruction. Cancers. 2021; 13(12):2852. https://doi.org/10.3390/cancers13122852

Chicago/Turabian Style

Twomey, Rosie, T. Wayne Matthews, Steven Nakoneshny, Christiaan Schrag, Shamir P. Chandarana, Jennifer Matthews, David McKenzie, Robert D. Hart, Na Li, Khara M. Sauro, and et al. 2021. "Impact of Early Mobilization on Recovery after Major Head and Neck Surgery with Free Flap Reconstruction" Cancers 13, no. 12: 2852. https://doi.org/10.3390/cancers13122852

APA Style

Twomey, R., Matthews, T. W., Nakoneshny, S., Schrag, C., Chandarana, S. P., Matthews, J., McKenzie, D., Hart, R. D., Li, N., Sauro, K. M., & Dort, J. C. (2021). Impact of Early Mobilization on Recovery after Major Head and Neck Surgery with Free Flap Reconstruction. Cancers, 13(12), 2852. https://doi.org/10.3390/cancers13122852

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop